Skip to main content

Table 2 Clinicopathological data of patients with ovarian cancer

From: Serum angiopoietin-2 and soluble VEGFR-2 levels predict malignancy of ovarian neoplasm and poor prognosis in epithelial ovarian cancer

Variable

Ovarian carcinoma

Total

75 (100)

Ascites

52 (69)

No ascites

13 (17)

No data (ascites)

10 (13)

Histological grade

 

1

12 (16)

2

28 (37)

3

35 (47)

Stage

 

I

10 (13)

II

6 (8)

III

42 (56)

IV

17 (23)

Primary residual tumor

 

None

27(36)

</=1 cm

9 (12)

> 1 cm

37 (49)

No data

2 (3)

Chemotherapy response

 

Complete response

54 (72)

Partial response

4 (5)

Stable disease

2 (3)

Progressive disease

4 (5)

No chemotherapy

4 (5)

No data

7 (10)

Tumor recurrence

 

No recurrence

18 (24)

Recurrence

43 (58)

No data

14 (19)

Patient status

 

Dead, ovarian cancer

44 (59)

Alive

29 (39)

Unknown

2 (3)

Median follow-up time, months

63 [0–162]

  1. Values are n (%).
  2. Values in square brackets indicate range.